Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
To streamline complex medical writing workflows with GenAI
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
ARGX-119 is the sixth molecule developed through our Immunology Innovation Program to show proof-of-concept
Subscribe To Our Newsletter & Stay Updated
